Array 20

Blood-Brain Barrier Permeability™
Assists in the assessment of increased risk of neurodegenerative disorders, including but not limited to Multiple Sclerosis, Lou Gehrig's Disease, Senile Dementia, Alzheimer's Disease, Parkinson's Disease, Epilepsy and Stroke. Helps in the early investigation of contact sports-related Traumatic Brain Injury (TBI), and evaluates the breach of Blood-Brain Barrier caused by stress, trauma or environmental triggers, even in the absence of apparent concussion or brain injury.

Clinical Use

  • Early investigation in management of contact sports-related Traumatic Brain Injury (TBI)

  • Evaluation of breach of the Blood-Brain Barrier by stress, trauma or environmental triggers, even in the absence of apparent concussion or brain injury

  • Assist in the assessment of increased risk of neurodegenerative disorders including, but not limited to, Multiple Sclerosis, Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease), Senile Dementia, Alzheimer's Disease, Parkinson's Disease, Epilepsy and Stroke

Recommended for Patients Who

  • Play contact sports during which repeated head trauma occurs

  • Engage in activity that involves force or shock to the body and/or head

  • Have intestinal permeability with abnormal elevation in LPS and/or Occludin/Zonulin antibodies

  • Exhibit changes in cognitive function

Antigens Tested

  • Blood-Brain Barrier Protein IgG + IgA combined
  • Blood-Brain Barrier Protein IgM
CPT® CODE : 83516 (x2)

Blood-Brain Barrier Permeability

Illustration dramatized for visual purposes. © Cyrex Laboratories, LLC. All rights reserved.

Contact Us

If you have any question you would like to know more about the
Array 2 - Intestinal Antigenic Permeability Screen™.
/form-thankyou

To Get Started

Cyrex Laboratories works with licensed healthcare professionals throughout the United States.
Create a healthcare professional account now!

If you're already a Cyrex Labs account holder, click here to log into your account to download additional materials.